Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy

Wojciech Szlasa1, Aleksander Kiełbik2,3, Anna Szewczyk3,4

  • 1Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Insights

Atorvastatin affects cancer cell membranes, altering electroporation efficacy. High voltage electroporation with calcium chloride is recommended for atorvastatin-treated cells to enhance treatment effectiveness.

Area of Science:

  • Biophysics
  • Cell Biology
  • Pharmacology

Background:

  • Electroporation efficacy depends on cell membrane properties like cholesterol and surface tension.
  • Actin fiber organization influences membrane surface tension.
  • Atorvastatin, a statin, modifies both cholesterol levels and actin organization.

Purpose of the Study:

  • To investigate the impact of atorvastatin on electroporation and electrochemotherapy in cancer cells.
  • To analyze how atorvastatin affects cell membrane properties and permeability.
  • To determine optimal conditions for electroporation in atorvastatin-treated cells.

Main Methods:

  • Cancer cell lines (MDA-MB231, DU 145, A375) were treated with atorvastatin (preincubation or direct).
  • Cholesterol content, actin organization, and membrane permeability were analyzed.
  • Cell viability after pulsed electric field (PEF) and calcium-enhanced electroporation (CaEP) was assessed.
  • N- and E-cadherin localization was examined using confocal microscopy.

Main Results:

  • Atorvastatin preincubation altered cholesterol levels and actin organization in a cell-line-dependent manner.
  • Actin reorganization increased the electroporation threshold under low voltage PEF.
  • High voltage PEF efficacy was modulated by changes in lipid composition.
  • Atorvastatin reduced low voltage PEF cytotoxicity but enhanced high voltage PEF cytotoxicity.

Conclusions:

  • Membrane surface tension regulates permeability under low voltage PEF.
  • High voltage electroporation combined with calcium chloride is suggested for atorvastatin-treated cells to overcome unfavorable effects and enhance efficacy.

Related Concept Videos

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
752
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
770
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
521
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
260